MYRIAD GENETICS INC. - COMMON STOCK

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

03 أبريل 2025 09:45:22 بحسب NetDania Notify

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

02 أبريل 2025 09:48:11 بحسب NetDania Notify

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

31 مارس 2025 09:45:54 بحسب NetDania Notify

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

28 مارس 2025 09:48:35 بحسب NetDania Notify

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

27 مارس 2025 16:08:08 بحسب NetDania Notify

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

26 مارس 2025 12:28:58 بحسب NetDania Notify

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

10 مارس 2025 11:06:23 بحسب NetDania Notify

Myriad Genetics and Gabbi to Work Together to Increase Access to Hereditary Cancer Risk Assessment Tools

27 فبراير 2025 16:15:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

25 فبراير 2025 09:46:27 بحسب NetDania Notify

Myriad Genetics Reports Fourth Quarter and Full-Year 2024 Financial Results; Full-year 2024 revenue of $838 million grew 11% year-over-year, the second consecutive year of double-digit revenue growth

24 فبراير 2025 16:05:01 بحسب Nasdaq GlobeNewswire

Myriad Genetics Announces Senior Leadership Transition

24 فبراير 2025 16:05:00 بحسب Nasdaq GlobeNewswire

Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio

24 فبراير 2025 08:30:00 بحسب Nasdaq GlobeNewswire

Myriad Genetics Included in Forbes America’s Best Employers 2025 List

19 فبراير 2025 08:30:00 بحسب Nasdaq GlobeNewswire

Myriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025

18 فبراير 2025 08:30:00 بحسب Nasdaq GlobeNewswire

Myriad Genetics and CancerCARE for Life Announce Agreement to Advance Access to MyRisk with RiskScore Hereditary Cancer Test

06 فبراير 2025 08:30:00 بحسب Nasdaq GlobeNewswire

Myriad Genetics Announces Two New Patents Granted for its Molecular Residual Disease (MRD) Assay

05 فبراير 2025 16:15:00 بحسب Nasdaq GlobeNewswire

Myriad Genetics and Lumea Collaborate to Enhance Access to the Prolaris Biomarker and MyRisk Hereditary Cancer Tests through BxLink Integration

05 فبراير 2025 08:30:00 بحسب Nasdaq GlobeNewswire

Myriad Genetics Unveils Groundbreaking Eight Weeks’ Gestation NIPT Study Results at Society for Maternal-Fetal Medicine Conference

29 يناير 2025 08:30:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

23 يناير 2025 10:36:25 بحسب NetDania Notify

Myriad Genetics Introduces Online Prenatal Genetic Testing Resource

23 يناير 2025 08:30:00 بحسب Nasdaq GlobeNewswire